We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+9.48%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$9.6B
AUM Growth
+$506M
Cap. Flow
-$208M
Cap. Flow %
-2.17%
Top 10 Hldgs %
16.85%
Holding
2,391
New
63
Increased
104
Reduced
1,016
Closed
90

Sector Composition

Rank Sector Weight
1 Technology 18.02%
2 Financials 14.83%
3 Healthcare 13.13%
4 Industrials 10.01%
5 Consumer Discretionary 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LFCR icon
2176
Lifecore Biomedical
LFCR
$183M
$137K ﹤0.01%
12,103
+6,649
+122% +$70.8K
STXB
2177
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
$136K ﹤0.01%
5,933
CAMP
2178
DELISTED
CalAmp Corp.
CAMP
$136K ﹤0.01%
619
LCI
2179
DELISTED
Lannett Company, Inc.
LCI
$136K ﹤0.01%
3,860
HZO icon
2180
MarineMax
HZO
$1.16B
$136K ﹤0.01%
8,159
RRBI icon
2181
Red River Bancshares
RRBI
$674M
$136K ﹤0.01%
+2,422
New +$115K
LL
2182
DELISTED
LL Flooring Holdings, Inc.
LL
$135K ﹤0.01%
13,856
NRIM icon
2183
Northrim BanCorp
NRIM
$595M
$135K ﹤0.01%
14,116
STOK icon
2184
Stoke Therapeutics
STOK
$2.13B
$135K ﹤0.01%
+4,762
New +$120K
FCBP
2185
DELISTED
First Choice Bancorp Common Stock
FCBP
$134K ﹤0.01%
+4,966
New +$114K
CVM icon
2186
CEL-SCI Corp
CVM
$26.6M
$134K ﹤0.01%
486
BFST icon
2187
Business First Bancshares
BFST
$1.04B
$133K ﹤0.01%
5,338
AMAL icon
2188
Amalgamated Financial
AMAL
$1.5B
$132K ﹤0.01%
+6,787
New +$125K
BLBD icon
2189
Blue Bird Corp
BLBD
$2.1B
$132K ﹤0.01%
5,751
TBIO
2190
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$132K ﹤0.01%
16,186
TLYS icon
2191
Tilly's
TLYS
$127M
$131K ﹤0.01%
+10,691
New +$113K
GPRO icon
2192
GoPro
GPRO
$114M
$131K ﹤0.01%
30,142
-22,423
-43% -$93.1K
MGTX icon
2193
MeiraGTx Holdings
MGTX
$1.21B
$131K ﹤0.01%
6,528
ACNB icon
2194
ACNB Corp
ACNB
$655M
$131K ﹤0.01%
3,451
HCAT icon
2195
Health Catalyst
HCAT
$132M
$131K ﹤0.01%
3,761
-3,228
-46% -$107K
RRD
2196
DELISTED
RR Donnelley & Sons Co.
RRD
$130K ﹤0.01%
+32,985
New +$130K
ARAY icon
2197
Accuray
ARAY
$34.6M
$130K ﹤0.01%
46,123
+36,408
+375% +$101K
BHR
2198
Braemar Hotels & Resorts
BHR
$138M
$130K ﹤0.01%
14,521
-145
-1% -$1.36K
GNTY
2199
DELISTED
Guaranty Bancshares
GNTY
$129K ﹤0.01%
4,316
CNBKA
2200
DELISTED
Century Bancorp Inc/Mass
CNBKA
$129K ﹤0.01%
1,431

Similar funds

MetLife Investment Management's Q4 2019 Portfolio in Review

As of Q4 2019, MetLife Investment Management held 2,391 positions worth $9.6B, up 5.6% from $9.09B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

MetLife Investment Management's Q4 2019 filing shows 63 new, 104 increased, 1,016 reduced and 90 closed positions. Its largest new stake was ServiceNow: 250,510 shares worth $14.1M. The largest sale was Celgene Corp, an estimated $19.2M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q4 2019 buy was ServiceNow: 250,510 shares worth $14.1M.
  • MetLife Investment Management added most to Bristol-Myers Squibb in Q4 2019, an estimated $10.2M increase.
  • MetLife Investment Management's biggest Q4 2019 reduction was Apple, cutting an estimated $12M.
  • MetLife Investment Management fully exited Celgene Corp in Q4 2019, selling an estimated $19.2M.
  • MetLife Investment Management's ten largest holdings make up 17% of its $9.6B portfolio in Q4 2019.
  • MetLife Investment Management opened 63 new positions and closed 90 in Q4 2019.
  • MetLife Investment Management's portfolio value rose 5.6% quarter-over-quarter to $9.6B.

Based on MetLife Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.